Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jana L. Jensen"'
Autor:
Eric M. Shobe, Jeffrey S. Day, Donald P. Smith, Joe Palandra, John D. Hosley, John J. Biermacher, Sandra M. Sims, Wade J. Adams, Philip S. Burton, Jana L. Jensen, Allen R. Hilgers, Janice M. Friis
Publikováno v:
Pharmaceutical Research. 20:1149-1155
Purpose. The purpose of this work was to evaluate an oral absorption prediction model, maximum absorbable dose (MAD), which predicts a theoretical dose of drug that could be absorbed across rat intestine based on consideration of intestinal permeabil
Publikováno v:
Pharmaceutical Research. 17:190-196
Purpose. We examined the metal-catalyzed oxidation of brain-derivedneurotrophic factor (BDNF) using the Cu(II)/ascorbate/O2 modeloxidative system.
Publikováno v:
Journal of the American Chemical Society. 119:4749-4757
Peroxynitrite can modify methionine by one- and two-electron oxidation pathways. Here, we have quantified the extent of one-electron oxidation of threonylmethionine (Thr-Met) by peroxynitrite using a characteristic reaction according to which Thr-Met
Publikováno v:
Journal of Pharmaceutical Sciences. 84:530-533
The feasibility of using modified Eudragit acrylic latexes as microporous coatings for osmotic devices was investigated. Potassium chloride tablets were coated with mixtures of Eudragit RS30D and RL30D acrylic latexes that also contained a plasticize
Autor:
Allen R, Hilgers, Donald P, Smith, John J, Biermacher, Jeffrey S, Day, Jana L, Jensen, Sandra M, Sims, Wade J, Adams, Janice M, Friis, Joe, Palandra, John D, Hosley, Eric M, Shobe, Philip S, Burton
Publikováno v:
Pharmaceutical research. 20(8)
The purpose of this work was to evaluate an oral absorption prediction model, maximum absorbable dose (MAD), which predicts a theoretical dose of drug that could be absorbed across rat intestine based on consideration of intestinal permeability, solu
Autor:
Jana L. Jensen, William R. Humphrey, Raymond J. Zielinski, Donald P. Smith, Ming-Shang T. Kuo, Gary E. Zurenko, John J. Biermacher, Ivan M. Richards, Mark H. Shattuck, Ronda D. Schaadt
The oxazolidinone linezolid represents a new antibacterial class of potential benefit in managing multidrug-resistant gram-positive infections, including those caused by Streptococcus pneumoniae . In a gerbil model of acute otitis media (AOM) induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4cd596d9655d4dac0aa511075557ac
https://europepmc.org/articles/PMC152499/
https://europepmc.org/articles/PMC152499/